| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |